CLINICAL AND LABORATORY FEATURES OF CHRONIC VIRAL HEPATITIS B, EFFECTIVENESS OF ETIOTROPIC THERAPY
Abstract
The main goal of CHB therapy is eradication of the virus with suppression of the necro-inflammatory process.
References
1. Sologub T.V., Romantsov M.G., Baranova I.P. and others. Combination therapy of chronic viral hepatitis B, resistant to treatment with lamivudine. West SPbSMA named after. I. I. Mechnikova 2006; 2: 7-13.
2. Sologub T.V., Romantsov M.G., Shuldyakov A.A. and others. Combination therapy for chronic viral hepatitis B and its impact on the quality of life. West SPbSMA named after. I. I. Mechnikova 2006; 1.
3. Lai C.L., Ratziu V., Yuen M.F., Poynard T. Viral hepatitis B. Lancet 2003; 362: 2089-2094.
4. Lok A.S., Heathcot E.J., Hoofnagle J.H. Management of hepatitis B: 2000 - summary of workshop. Gastroenterology 2001; 120: 1828-1853.
5. Lee W.M. Hepatitis B virus infection. N Ingl J Med 1997; 337: 1733-1745.
6. Ganem D., Prince A.M. Hepatitis B virus infection - natural history and clinical consequences. N Ingl J Med 2004; 350: 1118-1129.
